Yoon Sunwoo

Yoon Sunwoo

Auto-generated profile, based on publicly available information

Yoon Sunwoo

Department of Genomic Medicine, Seoul National University Hospital, South Korea; and

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2022 in Journal of Genetic Medicine
Verified
Journal Article
Open access
PDF file
YSYoon Sunwoo
Yoon Sunwoo
SSSoohyun Seo
Soohyun Seo
Ho-Joong KimHo-Joong Kim
Ho-Joong Kim
MPMoon Seok Park
Moon Seok Park
ACAnna Cho
Anna Cho
Yoon Sunwoo, Soo Hyun Seo, Ho-Joong Kim, Moon Seok Park, and Anna Cho. J Genet Med 2022;19:111-4. https://doi.org/10.5734/JGM.2022.19.2.111

13 May 2025 in Annals of Hematology
Verified
Journal Article
Open access
PDF file
YKYoung Dai Kwon
Young Dai Kwon
KHKyung Taek Hong
Kyung Taek Hong
JLJuyeon Lee
Juyeon Lee
YSYoon Sunwoo
Yoon Sunwoo
YKYeseul Kim
Yeseul Kim
HKHyoung Jin Kang
Hyoung Jin Kang
Inherited bone marrow failure syndromes are genetic hematologic disorders with increased cancer risk. Accurate diagnosis is crucial for appropriate management. This study assessed the clinical usefulness of next-generation sequencing (NGS)-based target gene sequencing in pediatric and AYA (adolescent and young adult) patients with hematologic abnormalities. From December 2019 to June 2023, 93 patients with suspected congenital hematologic diseases at a single institution underwent NGS-based testing. Medical records were retrospectively reviewed. The median age at diagnosis was 9.3 years (range 0.2–31.4), with 59.1% males. Indications for testing included specific medical histories (28 patients), persistent cytopenia or recurrent neutropenic fever (22 patients), changes in cytopenia patterns (11 patients), and other reasons (32 patients). Pathogenic variants were identified in 9/28 (32.1%), 3/22 (13.6%), 4/11 (36.4%), and 0/32 (0%). Overall, 16 patients (17.2%) had pathogenic variants, including FANCA, BRCA2, PMS2, ELANE, G6PC3 and VPS13B in patients with idiopathic neutropenia, and GATA2 in patients with suspected myelodysplastic syndrome. Genetic findings led to diagnostic revisions in 12 patients (12.9%), including reclassification of aplastic anemia (AA) as Fanconi anemia, Diamond-Blackfan anemia, or Shwachman-Diamond syndrome, prompting hematopoietic stem cell transplantation and altering cancer surveillance. Pathogenic variants were more frequently observed in patients with a specific medical history or changes in cytopenia, and in those with additional clinical features (cytogenetic abnormalities or non-severe AA). This study demonstrated the diagnostic usefulness of NGS-based target gene sequencing for pediatric and AYA patients with suspected genetic hematologic disorders, supporting the need for multicenter studies and standardized guideline development.

1 June 2026 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
JKJee Min Kim
Jee Min Kim
YSYoon Sunwoo
Yoon Sunwoo
HKHaeryung Kim
Haeryung Kim
YKYoung Ho Kim
Young Ho Kim
JCJong Ho Cha
Jong Ho Cha
JCJong-Hee Chae
Jong-Hee Chae
Background and ObjectivesArboleda-Tham syndrome (ARTHS) is a rare autosomal dominant neurodevelopmental disorder caused by pathogenic variants in the lysine acetyltransferase 6A (KAT6A) gene, chara...